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SUMMARY: Transdermal diffusion studies of a polyherbal ointment were carried out in vito 
using franz- Diffusion cell and microbial one inhibition diameter as drug release monitoring 
parameters.  Out of the three ointment base prepared, (Hydrocarbon Base (HB), surfactant Base 
(SB), Surfactant Base + (Penetration Enhancer (10 % DMSO) SBPE), we observed that SBPE 
possesses maximum drug release capacity, as indicated by simultaneous high performance liquid 
chromatograph (HPLC) and microbial one inhibition monitoring studies. Clinical observations 
showed at SBPE was effective in cases like infected wounds, scratches and abrasions, infected 
scabies, pyoderma and furunculosis.  The overall cure rate s 79.3% with the antimicro-bial 
ointmtmtent. 
 
INTRODUCTION 
 
Poly herbal formulations especially 
Ayurvedic products, are no evaluated in a 
proper manner in most of the quality control 
labs, the major draw back of the analysis, of 
these formulations is the lack of supply of 
the constituents having real pharmacological 
activity overlapping of spectal data etc, lack 
of availability of chemical markers and of 
bio availability test etc.  As the present work 
we have made an attempt to analyses an 
anti-microbial ointment by utilizing high 
performance liquid chromatography & 
bacterial zone inhibition studies which is 
used as a biopredictor.  The clinical 
efficiency of the ointment was received by 
choosing certain infections, skin diseases 
like, infected scabies, abressive scratches, 
pyoderma, etc. 
 
MATERIALS & METHODS  
(Raw Materials statdardisation) 
 
All the raw material used for the preparation 
of different ointment bases were 
standardized as per the I.P and B.P 
standards. 
 
All chemicals and organic solvents used 
were of analytical grade.  Crude drugs 
selected for this study were authenticated at 
the Tamil nadu Agricultural University, 
coimatore and also at the department of 
pharmacogonosy and photochemistry, 
SRIPMS, Coimbatore. Various 
Pharmacogonostic, phytocemical , physical 
and microbial contamination tests were 
carried out according to the standard 
procedures as described in I.P., British 
herbal pharmacopoeia, Ayurvedic 
pharmacopoeia Ayurvedic Pharmacopoeia 
of India, W.H.O guidelines and also by 
referring to various published 
literatures.
1,2,3,4,5,6,7,19. 
 
Five crude drugs reported to have a good 
antimicrobial activity
8,9,10.  Were selected 
for making the ointment formulation.  They 
were Nigella sativa, Rubia cordifolia, 
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Pongamia glabra, Mallotus-phillipihensis 
and psorelea corlifolia.  Suitable solvent 
extracts were prepared from these crude 
drugs according to the positive tests 
indicated by phytochemical analysis
20 
(Table-1). 
 
Table 1 Solvent 
Pretocol for solvent extraction of crude drugs 
 
Sl. 
No 
Drugs used  Official 
part 
Wt of 
saper 
Vol of org. Solution  Duration 
of 
extract 
Yield 
1 
2 
3 
 
 
 
4 
 
5 
Nigella sativa 
Rubia cardifolic 
Pongamia glabra 
 
 
 
Mallotus 
phillipinesis 
Psorelea 
Conlifolia 
Seeds 
Stem 
Seeds 
 
 
 
Glands 
and 
hairs of 
fruit 
seeds  
500g 
500g 
250g 
 
 
 
200g 
 
500g 
70% ethanol 
70% ethanol 
Per ether for a fatty 
and methanol for 
extract 
Absolute alcohol 
 
Per ether for 
defaulty methanol  
1 week 
2week 
2hrs 
 
 
 
3hrs 
 
5hrs 
24.8 % W/W 
19.2 % W/W 
37.6 % W/W 
 
 
 
3.2 a% 
 
20.4 % 
 
APPARATUS AND CONDITIONS  
 
HPLC Marking procedure for Individuals 
Drugs water HPLC system was used for the 
analysis.  The column used was Zorbax C8 
Revserse phase column). A mixture of 
acetonitrille: 50ml disodium hydrogen 
orthophosphate (adjusted to pH3.5 using 
orthophosphoric acid) 50:50 v/v was used as 
moil phase at a flow rate of 1.5ml/minute 
with an operating pressure of 3000psi. A 
rheodyne 7125 injection of samples.   
Detection was done t 215nm, with a 
sensitivity of 0.2 AUFS.  The mobile phase 
was filtered trough 0.45u membranes filter 
and degassed.  The separation was carried 
out at the room temperature of about 20
oC 
(11, 12). 
 
PREPARATION OF STANDARD 
SOLUTIONS 
 
Standard stock solutions of P.glabra (PG), 
Psorelea corylifolia (PC), N. Sativa (NS), R. 
corclifolia (RC) and M.Phillipinensis (MP) 
were prepared after suitable dilution wit 
mobile phase, 20uL of standard stock 
solution of PG, PC, NS, MP, RC were 
injected and the chromatograms were 
recorded. From the individual 
chromatogram the peaks of individual drugs 
were observed and the peaks for analysis 
were selected which are not interfering with 
the peaks of other drugs in the 
chromatogram.  Again another 
chromatogram was recorded by combining 
all drugs extracts n equal quantities (4uls 
each) to make a volume of 20u ls.  A 
computer controlled data station with 
baseline 810 software was used to plot the 
peak area Vs. Concentration in µg/ml. 
 
PREPARATION OF OINTMENT 
BASES 
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Three ointment bases were prepared for the 
evaluation 3, 12.  They were (a) 
hydrocarbon base (B), (b) surfactantbase 
(SB), (c) surfactant base with a penetration 
enhancer (10% dimethyl sulfoxide) 
designated as SBPE. All the ointment bases 
were formulated using chemicals of a 
analytical grade and prepared as per B.P. 
standards.  Plant drug extracts were 
incorporated individually in all the four 
bases.  As there are five different types 
included in the ointment bases, 10% of each 
drug was added to the ointment bases and 
homogenized. 
 
TRANSDERMAL ABSORPTION 
STUDIES  
 
Diffusion cell 10cm x 2.3cm dimension was 
used for the study.  2.5gms of the abdominal 
rat skin, which was tied to the diffusion cell 
in a way that the ointment occupies the inner 
side of the diffusion cell.  The diffusion cell 
was placed in a beaker (250ml capacity), 
containing 100ml of pH 7.2 buffer.  In order 
to maintain uniform mixing the medium was 
stirred at a constant speed with a magnetic 
stirrer.  At regular intervals of time (ever 
one hour upto 5
th hour); withdrawn specific 
volume of the medium (2ml) form the 
diffusion cell and maintained the level of the 
medium constant by replacing fresh medium 
into the cell.  The whole diffusion cell was 
placed in an organ broth at 37oC ± 0.5oC.  
These withdrawn samples were diluted 
(100times) with the mobile phase of the 
HPLC system and analyses 14-16.   
simultaneously these withdrawn samples at 
definite time intervals were tested for its 
antimicrobial activity by zone imbibitions 
diameter method using two different kinds 
of bacterial strains (gram positive and gram 
negative), and two strains of fungi (candida 
albicans, Cadida tropicalis).  The experiment 
was repeated three times for individual 
ointment bases and tabulated the mean of 
the values.  From HPLC data the individual 
drug release in the withdrawn samples were 
identified.  (Table 2-7). 
 
Table -2 
Drug release concentration profiles for different ointment formulations from HPLC data (HB, SB, SBP) 
Drug release profiles in mg/grams of total drug extract 
 
Formulation    1hr  2hr  3hr  4hr 5hr Total  Drug 
Released at the 
end of 5
th hour 
SBP 
HB 
SB 
0.3221 
0.1090 
0.62504 
0.71438 
0.1461 
0.7299 
0.7628 
0.1752 
0.8009 
0.7686 
0.2135 
0.8586 
0.7733 
0.2260 
0.9035 
3.5448 
0.8698 
3.0139 
    
Table -3 
 
Chemical marking procedures for individual drugs using high performance Liquid 
chromatography 
 
Drug 
Retention 
time 
Specific 
peak 
selected as 
marker 
Peak Area  Peak Height  Solution 
concentration 
(ngs/ml)  
 
Pongamia glabra 
1.40 
2.29 
3.467 
 
3.467 
 
266209 
16316 6.82 
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4.89 
 
Psorelea conlifolia 
1.47 
2.28 
3.18 
4.98 
6.29 
7.50 
8.45 
 
 
4.98 
 
 
2060508 
 
 
14967 
 
 
1.40 
 
Mallotus Phillipinesis 
2.23 
2.98 
4.92 
5.48 
6.74 
7.5 
8.11 
7.03 
9.98 
10.71 
11.83 
 
 
6.74 
 
 
171407 
 
 
8995 
 
 
4.24 
 
Rubia cordifolia 
2.32 
4.23 
5.02 
6.49 
8.94 
 
8.94 
 
2968935 
 
148021 
 
8.50 
 
Nigella Sativa  
2.33 
4.10 
6.17 
6.96 
7.73 
8.5 
 
6.17 
 
50369 
 
2982 
 
5.62 
 
Table -4 
Drug release profile for different ointment bases monitored by microbial zone of inhibition 
diameter 
Micro Organism used: Escheriachia coil (gram-ve) 
 
Zone pf Inhibition in diameter (mm) 
Time in Hours 
SBPE SB  HB 
1hr  10.26 ± 0.288  8.01 ± 0.312  8.10 ± 0.278 
2hr  18.51 ± 0.272  18.22 ± 0.276  0.32 ± 0.266 
3hr  18.42 ± 0.229  16.76 ± 0.277  8.66 ± 0.298 
4hr  18.42 ± 0.284  16.70 ± 0.398  9.28 ± 0.394 
5hr  18.50 ± 0.347  16.72 ± 0.292  9.32 ± 0.321 
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Table – 5 
Micro Organism used: Staphylococcus aureus (gram-ve) 
 
Zone pf Inhibition in diameter (mm) 
Time in Hours 
SBPE SB  HB 
1hr  5.16 ± 0.477  9.11 ± 0.288  6.07 ± 0.342 
2hr  16.92 ± 0.277  14.32 ± 0.276  6.12 ± 0.387 
3hr  18.08 ± 0.216  14.5 ± 0.312  7.20 ± 0.261 
4hr  18.04 ± 0.321  14.62 ± 0.264  7.23 ± 0.293 
5hr  18.03 ± 0.321  15.0 ± 0.292  7.31 ± 0.217 
   
  Table – 6 
Micro Organism used: Candida albicans  
 
Zone pf Inhibition in diameter (mm) 
Time in Hours 
SBPE SB  HB 
1hr 16.92±  0.229  8.92±0.424  5.5±0.424 
2hr  20.32 ± 0.286  12.02±0.398  5.92±0.312 
3hr 20.48±0.394  12.24±0.226  6.28±0.298 
4hr 21.0±0.314  12.36±0.310  8.42±0.29 
5hr 20.64±0.298  13.31±0.348  8.5±0.346 
   
Table – 7 
Micro Organism used: Candida Tropicalis 
 
Zone pf Inhibition in diameter (mm) 
Time in Hours 
SBPE SB  HB 
1hr 12.8±0.342  14.2±  0.342  5.0±0.232 
2hr 20.48±0.286  19.60±0.198   5.18±0.286 
3hr  21.36 ± 0.512  20.45±0.414   5.36±0.394 
4hr  22.92 ± 0.492  20.76±0.472   6.26±0.261 
5hr  22.68 ± 0.311  20.95±0.268   6.33±0.386 
   
SB – Surfactant base 
SBP – Surfactant base = Permeation enhancer HB – Hydrrocarbon base  
(100% DMOO) 
 
PREPARATION OF THE SKIN MEMBRANE  
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The excised shaven abdominal skin [3.5, 
3.5] of five to seven weeks old albino mouse 
of either sex was used.  The skin was 
washed with distilled water placed in normal 
saline for 5-10 minutes and used for fixation 
in the diffusion cell
17 
 
TOPICALSENSITIVITY TEST 
 
All the four ointment ( A B ,  H B ,  S B  a n d  
SBPE) were tested for their skin sensitivity 
tests by applying to the elbow of the hand in 
selected human volunteers and observed the 
side effects if  any, as a set of parameters 
like skin inflammation, skin irritation 
reddening of skin (allergic reactions) etc.   
None of the four ointments showed any 
allergic reactions. 
 
CHEMICAL MAKING PROCEDURES 
 
The characteristic peak responsible for the 
crude was selected and kept ad the marker 
for the particular drug.  In a similar manner 
all drugs were characterized by their specific 
peaks which were not overlapping with one 
another
18.  The characteristic peaks 
responsible for individual drugs were 
tabulated as shown in (Table -2). 
 
CLINICAL TRIAL METHOD 
 
30 patients of the dermatology Out – patient 
Department, chaitanya Nursing Home North 
parur, Ernakulam, Kerala, were selected for 
study, including various primary and 
secondary infections like abrasions and 
scratches, infected wounds infected scabies 
pyoderma and furunculosis. 
 
A pre-treatment culture swab was initially 
taken from each patients skin lesions to 
examine sensitivity.  The patients were 
subsequently instructed to apply herbal 
antimicrobial ointment dispensed to them 
the herbal ointment was to be applied 
insufficient quantity over the skin lesions 
twice a day after initial removal of the 
crusted exudates with saline soaks. 
 
The clinical diagnosis and anatomical 
distribution were recorded in every patient. 
Six patients in each of the cases mentioned, 
were selected for experimenting the efficacy 
of ointment, the maximum duration allotted 
was for a period of 7 days for monitoing % 
curation rate.  The criteria for clinical 
assessment are summarized in Table – 8, 9 
and 10. 
Table – 8 
Criteria for clinical assessment 
 
Cure Rate  Complete Clearance of Lessions 
25% improvement   +( Very little noticeable improvement ) 
50% improvement  ++(Discharge), Scab ++, Moderate Erythema 
75%  improvement  +++ no visible discharge, pyogenic scab has cleared & 
very little Erythema   
100% improvement  ++++ Completely cured. 
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Table -9 
Curative potency of the formulation SBPE 
 
Type of lessons  Days cure Rate % 
1 2 3 4 5 6 7   
Abrasions and 
scratches Case -1 
Nil  4.16 8.3  29.16 33.3 75.0 83.8 
Infected wounds 
Case -II 
Nil  8.3  12.5 20.8 29.16 50.0 79.16 
Infected scabies 
Case –III 
Nil  4.20 8.3  25.0 37.5 50.0 79.2 
Pyoderma 
Case –IV 
Nil  5.20 12.5 20.5 37.5 70.8 80.5 
Furunculosis 
Case - V 
Nil Nil 8.3 16.6  29.16 58.33  75.0 
 
Table – 10 
 
Curative potency of the formulation studies (SBPE) 
 
Cases Cured Improved Total 
Case - I  2  4  6 
Case – II  1  4  6 
Case – III  1  4  6 
Case – IV  1  3  6 
Case – V  -  4  6 
Total 5  19  30 
% 16.0 63.33 79.33 
 
SBPE: Surfactant Baset Penetration enhancer 
 
As mentioned in Table 10 30 patients were 
selected in this screening studies of which 
5(16%) were cured and19 were improved 
(63.33%) which included 5 different cases 
mentioned.  Te overall clinical success rate 
was 79.33% with this polyherbal 
antimicrobial ointment. 
 
RESULTS AND DISCUSSIONS  
 
The percutaneous absorption studies 
monitored by t bacterial one inhibition 
method to predict the efficacy of an 
ointment formulation to release drugs can be 
very well used as a biopredictor for this type 
of drug trials. 
 
For a poly herbal ointment it is very difficult 
to study the drug release profiles as well as 
the concentration of the drug released at 
ever our.  Monitoring with HPLC for finding 
our the release pattern for any type of 
ointment bases also provides important 
information regarding the capacity of the 
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ointment of release various active 
constituents.  Also one can use HPLC for 
making different category of dugs according 
to its content of active constituents, this will 
be f helpful again to monitor any particular 
drug in poly herbal ointment for its 
identification and also for finding our the 
concentration of the chemical substances 
released form base.  Therefore the efficiency 
of the polyherbal ointment can be predicted 
confidently by utilizing these two techniques 
together i.e. the bacterial zone inhibition 
diameter (can be used as drug release 
monitoring parameter) and the HPLC 
monitoring (can be used as chemical 
marker) applying simultaneously to study 
sample drug solution at periodic time 
intervals from diffusion cell. 
 
Topical sensitivity test for the ointments 
prepared, revealed the safty of the 
preparation i.e. without the production of 
any type of side effects.  The data obtained 
form bacterial one inhibition diameter & 
HPLC showed that SBP (surfactant base + 
permeator enhance 10% DMSO) Having 
drug release maximum at the time interval 
of 2
nd 3
rd hour.  Surfactant base (SB) is 
having a release maximum at 3
rd hour to 4
th 
hours.  Hydro carbon base “drug release 
data” showed that it can release maximum at 
3
rd hour to 4
th hour Hydro carbon base “drug 
release data” showed that it can release 
drugs at a constant rate but the concentration 
of the drug release will be very less.  
 
Clinical observation studies for the SBPE 
(surface base + Penetration Enhancer) 
showed that this, herbal antimicrobial 
ointment can be use days an effective topical 
medications for various infected skin 
conditions.  The overall clinical success rate 
was 79.33% with this polyherbal ointment 
preparation. 
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